Quince Therapeutics (QNCX) Sale and Maturity of Investments (2019 - 2026)
IRulya Therapeutics (QNCX) reported Sale and Maturity of Investments - Total of $12 million for Q1 2026, down 7.7% from $13 million a year earlier and down 7.7% from the prior quarter.
Powered by 
Analysis
Quince Therapeutics (QNCX) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends
For FY2025, IRulya Therapeutics posted Sale and Maturity of Investments - Total of $58 million, down 48.1% from FY2024.
- Sale and Maturity of Investments - Total has a five-year compound annual growth rate of -15.5% (FY2020 to FY2025).
- By year, Sale and Maturity of Investments - Total came in at $111.73 million in FY2024 (+0.5%), $111.21 million in FY2023 (+34.8%), $82.49 million in FY2022 (-15.8%) and $97.92 million in FY2021 (-27.3%).
- The Q1 2026 figure ranks as the lowest quarterly Sale and Maturity of Investments - Total since Q4 2024.
- Year over year, Sale and Maturity of Investments - Total gained in three of the last eight quarters, with an average decline of 17.6%.
- The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q1 2024 (growth of 263.4%); the low point was Q3 2021 (a decline of 79.1%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $13 million (Q4 2025), $14 million (Q3 2025) and $18 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 1.30 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 136.00 Mn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.03 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.12 Bn |
| 10 | IRulya Therapeutics | 201.34 Mn | 229.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 10.99 Mn |
| Jun 30, 2024 | 41.49 Mn |
| Mar 31, 2024 | 48.25 Mn |
| Dec 31, 2023 | 26.70 Mn |
| Sep 30, 2023 | 49.12 Mn |
| Jun 30, 2023 | 22.12 Mn |
| Mar 31, 2023 | 13.28 Mn |
| Dec 31, 2022 | 27.00 Mn |
| Sep 30, 2022 | 21.11 Mn |
| Jun 30, 2022 | 12.01 Mn |
| Mar 31, 2022 | 22.38 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Sep 30, 2021 | 11.38 Mn |
| Jun 30, 2021 | 18.91 Mn |
API Access
Quince Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=QNCX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "QNCX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=QNCX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();